Karsa’s powerful molecular detection technology has applications beyond homeland security and climate change research. Our chemical analysis platform eliminates laborious workflows for the analysis of small molecules. We want to bring this approach to the IVD market with analysis of bodily fluids.
Being selected for batch 3 of the Health Incubator Helsinki will enable Karsa to shape the product offering, engage potential customers and stakeholders, and generate a solid plan on how to best navigate the barriers to entry of the health sector.
Read more: Health Incubator Helsinki
